Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness Biotech Investing
Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S. FDA for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults Pharmaceutical Investing
SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HYZN, INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Biotech Investing
SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations Pharmaceutical Investing
BRISTOL MYERS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY Biotech Investing
Health Canada Approves the Use of RINVOQ® for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
AbbVie's RINVOQ® Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis Biotech Investing
InvestmentPitch Media Video Discusses Love Pharma's Appointment of Joshua Maurice as its Chief Operating Officer - Video Available on Investmentpitch.com Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Home BancShares, Valley National, Kraton Corporation, and Acceleron Pharma on behalf of Stockholders and Encourages Investors to Contact the Firm Pharmaceutical Investing
